SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rob LeVine who wrote (19)12/19/1996 5:51:00 AM
From: Thomas G. Magnani   of 369
 
One thing that scares me about this treatment for incontinence is the rather high incidence of infection. Although Individual Investor disregards this downside, I think it is a significant drawback to the treatment. Afterall, a chronic urinary tract infection is nothing to ignore since antibiotics can become ineffective if used too often. Just my thoughts on some of the lack of enthusiasm reflected in the stock price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News